Cargando…
Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescription analgesics (NOAs, e.g., gabapentinoids) despite...
Autores principales: | Bonnet, Udo, Specka, Michael, Soyka, Michael, Alberti, Thomas, Bender, Stefan, Grigoleit, Torsten, Hermle, Leopold, Hilger, Jörg, Hillemacher, Thomas, Kuhlmann, Thomas, Kuhn, Jens, Luckhaus, Christian, Lüdecke, Christel, Reimer, Jens, Schneider, Udo, Schroeder, Welf, Stuppe, Markus, Wiesbeck, Gerhard A., Wodarz, Norbert, McAnally, Heath, Scherbaum, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649209/ https://www.ncbi.nlm.nih.gov/pubmed/33192740 http://dx.doi.org/10.3389/fpsyt.2020.592199 |
Ejemplares similares
-
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
por: Bonnet, Udo, et al.
Publicado: (2021) -
Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
por: Claus, Benedikt Bernd, et al.
Publicado: (2020) -
Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates
por: Bonnet, Udo, et al.
Publicado: (2022) -
Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2020) -
Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2021)